SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vista Pharmaceuticals informs about outcome of board meeting

30 Dec 2023 Evaluate
Vista Pharmaceuticals has informed that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act, 2013 on 14th October, 2022 and In- principle approval received from BSE on 30.11.2022, and the allotment of warrants dated 14th December 2022, the allotment of 5,33,333 equity shares of Rs 2 in the Company’s Equity Share Capital, on conversion of 5,33,333 Warrants, be and are hereby allotted to the person as mentioned below at a price of Rs 10 per equity shares includes a premium of Rs 8 per share: for which the Board of Directors have accorded their approval, at their meeting held on 30th December, 2023 Commenced at 10.00 PM and Concluded at 10:15 AM.

The above information is a part of company’s filings submitted to BSE.

Vista Pharma Share Price

7.98 0.28 (3.64%)
24-Apr-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.50
Dr. Reddys Lab 1312.40
Cipla 1295.00
Zydus Lifesciences 930.00
Lupin 2285.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×